Market Tracker

09/23 5:16pm ET

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

5.62
Delayed Data
As of Sep 23
 -0.20 / -3.44%
Today’s Change
3.60
Today|||52-Week Range
12.60
-6.33%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close5.82
Today’s open5.84
Day’s range5.51 - 5.89
Volume63,603
Average volume (3 months)323,996
Market cap$21.2M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+49.44%
Earnings growth (this year)+27.96%
Earnings growth (next 5 years)--
Revenue growth (last year)+12.11%
P/E ratioNM
Price/Sales8.37
Price/Book0.88

Competitors

 Today’s
change
Today’s
% change
WINTWindtree Therapeutic...-0.09-3.32%
BLPHBellerophon Therapeu...+0.06+4.16%
ACSTAcasti Pharma Inc+0.01+0.53%
ONTXOnconova Therapeutic...+0.18+6.16%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.94
Annual revenue (last year)$1.9M
Annual profit (last year)-$14.3M
Net profit margin-737.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts